New Jersey-based Zoetis Inc. (ZTS) is the world's leading animal health company, focused on advancing the care of animals through innovation and science. With nearly 75 years of experience, the company develops products and solutions that help predict, prevent, diagnose, and treat diseases in both companion animals and livestock.
Serving veterinarians, pet owners, and livestock producers in more than 100 countries, Zoetis combines scientific research, advanced manufacturing capabilities, data-driven development, and commercial expertise to deliver a broad portfolio of medicines, vaccines, diagnostics, biopharmaceuticals, and digital health solutions. With a market capitalization of approximately $32.03 billion, Zoetis comfortably falls into the large-cap category, which generally includes companies valued at $10 billion or more.
Investors Bearish on Oracle Ahead of Earnings - Unusually Heavy ORCL Put Options Trading
Salesforce vs. ServiceNow: 1 AI Giant Is Leaving the Other Behind
Microsoft Stock Is Up Nearly 30% From Its March Lows, But You Shouldn’t Sell MSFT Just Yet
Serving veterinarians, pet owners, and livestock producers in more than 100 countries, Zoetis combines scientific research, advanced manufacturing capabilities, data-driven development, and commercial expertise to deliver a broad portfolio of medicines, vaccines, diagnostics, biopharmaceuticals, and digital health solutions. With a market capitalization of approximately $32.03 billion, Zoetis comfortably falls into the large-cap category, which generally includes companies valued at $10 billion or more.
Investors Bearish on Oracle Ahead of Earnings - Unusually Heavy ORCL Put Options Trading
Salesforce vs. ServiceNow: 1 AI Giant Is Leaving the Other Behind
Microsoft Stock Is Up Nearly 30% From Its March Lows, But You Shouldn’t Sell MSFT Just Yet
8 hours ago
